Literature DB >> 1739607

Selectivity and potency; are we doing the right things to find anti-cancer agents with these properties?

J A Double.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1739607      PMCID： PMC1977735          DOI： 10.1038/bjc.1992.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  6 in total

1.  Antibody-directed enzyme prodrug therapy.

Authors:  T A Connors
Journal:  Cancer Cells       Date:  1990-02

2.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

Review 3.  A critical appraisal of the predictive value of in vitro chemosensitivity assays.

Authors:  R M Phillips; M C Bibby; J A Double
Journal:  J Natl Cancer Inst       Date:  1990-09-19       Impact factor: 13.506

4.  Clinical drug development: an analysis of phase II trials, 1970-1985.

Authors:  S Marsoni; D Hoth; R Simon; B Leyland-Jones; M De Rosa; R E Wittes
Journal:  Cancer Treat Rep       Date:  1987-01

Review 5.  Therapeutic index: a vital component in selection of anticancer agents for clinical trial.

Authors:  J A Double; M C Bibby
Journal:  J Natl Cancer Inst       Date:  1989-07-05       Impact factor: 13.506

6.  Flavone acetic acid--an interesting novel therapeutic agent or just another disappointment?

Authors:  M C Bibby
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640
  6 in total
  2 in total

1.  Acute effects of 4-ipomeanol on experimental lung tumors with bronchiolar or alveolar cell features in Syrian hamsters or C3H/HeNCr mice.

Authors:  S Rehm; D E Devor
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  Effect of cisplatin on primary tumour growth and liver metastases in the M 5076 reticulum sarcoma: implication for new screening modalities.

Authors:  M Schirner; M R Schneider
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.